SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-003880
Filing Date
2024-01-17
Accepted
2024-01-17 06:05:45
Documents
14
Period of Report
2024-01-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191729-8k_incannex.htm   iXBRL 8-K 27860
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED JANUARY 17, 2024 ea191729ex99-1_incannex.htm EX-99.1 21024
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3710
  Complete submission text file 0001213900-24-003880.txt   234983

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20240117.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20240117_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20240117_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea191729-8k_incannex_htm.xml XML 3395
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 24536652
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)